Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance

Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML allianceEarly BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance, Published online: 15 June 2018; doi:10.1038/s41408-018-0093-4Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance

Source: Blood Cancer Journal - June 15, 2018 Category: Hematology Authors: Jingru Zhang Yingqiao Wang Jianxiang Wang Jianda Hu Suning Chen Jie Jin Ting Liu Jianfeng Zhou Yu Hu Daoxin Ma Xiaojun Huang Chunyan Ji Ming Hou Source Type: research